Add GLP-1 Weight Loss to Your Florida MedSpa

What is a medspa GLP-1 program in Florida?

Put simply, a medspa GLP-1 program turns the weight loss questions your Florida clients already ask into a structured, recurring service. Clients enroll under your medspa’s brand, complete an online health history, and meet a provider licensed in Florida by video, who decides whether semaglutide or tirzepatide is appropriate. Approved prescriptions ship from an FDA-registered 503A or 503B pharmacy, and refills, check-ins and billing run automatically. Telehealth Grow provides the prescribers, protocols, consent templates and EMR, so your aestheticians and front desk can focus on consultations, package sales and complementary treatments like body contouring and skin tightening.

Why Florida is a strong market for a medspa GLP-1 program

Florida has an estimated 23,462,518 residents (U.S. Census Bureau, 2025), ranking 3rd among the 50 states and D.C., and its population has grown 8.9% since the 2020 Census.

Demand is concentrated in Jacksonville (1M), Miami (490K), Tampa (414K) and Orlando (334K), but a telehealth model lets one brand serve patients statewide — including smaller towns and rural counties where in-person weight loss clinics are scarce.

The capital, Tallahassee, and the rest of the state run primarily on Eastern Time, so patient support and provider availability can be scheduled around local business hours.

In Florida, 28.4% of adults were living with obesity in 2020 CDC Behavioral Risk Factor Surveillance System (BRFSS) data — below the median across U.S. states of 31.3%. Applied to the state’s adult population, that suggests roughly 5,197,400 adults who could be candidates for a GLP-1 conversation with a licensed provider.

The South and Midwest have the highest adult obesity prevalence of the four U.S. Census regions in CDC data, so demand for medically supervised weight loss here is structural, not a passing trend.

For medspas and aesthetic practices, Florida offers the scale and demand to support a medspa GLP-1 program built on monthly subscriptions rather than one-off sales.

Florida telehealth rules to know before you launch

The American Association of Nurse Practitioners (AANP) classifies Florida as a restricted practice state: nurse practitioners need career-long supervision, delegation or team management by a physician. A compliant GLP-1 program here needs a physician medical director and documented supervision arrangements — both of which Telehealth Grow’s provider network supplies.

• Provider licensure: the prescribing clinician must be licensed in the state where the patient is located at the time of the visit — here, Florida.
• Telehealth prescribing: semaglutide and tirzepatide are not DEA-controlled substances, so they can generally be prescribed after a valid telehealth consultation. Adding controlled medications such as phentermine brings extra Ryan Haight Act and DEA telemedicine requirements.
• Ownership structure: corporate practice of medicine rules limit who may own a medical practice and vary by state. The MSO-PC model separates the business you own from the clinical practice that delivers care.
• Compounded medications: must come from state-licensed 503A pharmacies or FDA-registered 503B outsourcing facilities, and FDA compounding policy shifts as drug-shortage status changes.
• Advertising: Google and Meta require LegitScript certification for many telehealth and pharmacy ads — we support the application.

This section is general information, not legal advice. Regulations change, and Telehealth Grow’s compliance team verifies current Florida requirements for your specific business during onboarding.

Revenue potential in Florida

Here is an illustrative projection. If a medspa GLP-1 program in Florida reached just 0.05% of the adults estimated to be living with obesity, and each active patient generated about $120 in monthly profit (the benchmark used in our revenue calculator), the numbers would look like this:

Illustration only, not a guarantee. Actual revenue depends on medication costs, dosages, pricing, telehealth visit fees, marketing spend and patient retention.